To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
- Today’s Promising Areas of Cancer Research
- What is Cancer?
- A Broken Pipeline?
A Generation of Science at Risk
- ARISE Report
Early Career Scientists and High-Risk, High Reward Research - American Academy of Arts and Sciences
- Why We’re Losing the War on Cancer (And How To Win It)
Clifton Leaf - Fortune Magazine
October 2, 2006
Terry L. Orr-Weaver, PhD (Damon Runyon Scientific Advisory Committee Member '02-'06), Member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology, is the newest American Cancer Society research professor. She was chosen for her numerous contributions to both cancer biology as well as our basic understanding of how cells divide. Dr. Orr-Weaver plans to continue her studies with MEI-S332, a protein she first discovered in flies, which has now been identified at high levels in human breast cancer.